SLN
Silence Therapeutics plc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No N-PORT holders.
—
Expected move
Inputsspot 19.75exp Nov 20ATM strike 20ATM straddle 0.25IV 3%
—
No thesis.
Silence Therapeutics plc
19.76
−0.04 · −0.20%
post 19.76 0.00%
Linked news
News| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | SirenSiren | $36.4M | 14.46% | +13.74% | |
| 2 | TCG Crossover ManagementTCG Crossover | $33.3M | 13.25% | 0.00% | |
| 3 | Redmile GroupRedmile | $23.8M | 9.45% | 0.00% | |
| 4 | Nantahala Capital ManagementNantahala | $14.8M | 5.88% | −37.27% | |
| 5 | Citadel AdvisorsCitadel | $14.6M | 5.81% | +6.70% | |
| 6 | Polygon ManagementPolygon | $11.7M | 4.65% | +68.89% | |
| 7 | Nextech InvestNextech Invest | $10.5M | 4.16% | 0.00% | |
| 8 | Millennium ManagementMillennium | $10.0M | 3.97% | −15.35% | |
| 9 | Ikarian CapitalIkarian Capital | $9.1M | 3.63% | −4.04% | |
| 10 | Soleus Capital ManagementSoleus | $6.9M | 2.75% | new | |
| 11 | Balyasny Asset ManagementBalyasny | $6.7M | 2.67% | new | |
| 12 | 5AM Venture Management5AM Venture | $5.2M | 2.08% | 0.00% | |
| 13 | Caption ManagementCaption | $5.1M | 2.01% | new | |
| 14 | Great Point PartnersGreat Point Partners | $4.9M | 1.97% | −55.90% | |
| 15 | Morgan StanleyMorgan Stanley | $4.4M | 1.76% | +515.66% | |
| 16 | Jane Street GroupJane Street | $4.3M | 1.69% | +283.99% | |
| 17 | Ameriprise FinancialAmeriprise Financial | $4.1M | 1.62% | new | |
| 18 | ADAR1 Capital ManagementADAR1 | $3.7M | 1.48% | +96.55% | |
| 19 | SummitTX CapitalSummitTX Capital | $3.6M | 1.43% | new | |
| 20 | Schonfeld Strategic AdvisorsSchonfeld Strategic | $3.0M | 1.18% | new | |
| 21 | UBS GroupUBS | $2.7M | 1.06% | −1.53% | |
| 22 | Susquehanna International GroupSusquehanna International | $2.6M | 1.02% | +51.39% | |
| 23 | BlackRockBlackRockindex-like | $2.4M | 0.96% | +7.39% | |
| 24 | Bank of MontrealBank of Montreal | $2.2M | 0.88% | −0.58% | |
| 25 | Boothbay Fund ManagementBoothbay Fund | $2.2M | 0.87% | −5.14% |
71 managers report $251.4M of Silence Therapeutics on form 13F for the quarter ended Jun 30 '26. 16 of them hold 80% of it; Siren is largest at 14.46%.